Susquehanna International Group
BBH icon

Susquehanna International Group’s VanEck Biotech ETF BBH Stock Holding History

Susquehanna International Group’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.09M Sell
5,800
-6,300
-52% -$1.21M ﹤0.01% 7661
2025
Q4 		$2.29M Buy
12,100
+9,400
+348% +$1.74M ﹤0.01% 5357
2025
Q3 		$447K Buy
2,700
+300
+13% +$48.9K ﹤0.01% 9214
2025
Q2 		$368K Buy
2,400
+1,100
+85% +$164K ﹤0.01% 9880
2025
Q1 		$205K Buy
+1,300
New +$211K ﹤0.01% 10886
2023
Q3 		– Sell
-1,300
Closed -$203K – 12005
2023
Q2 		$203K Buy
+1,300
New +$208K ﹤0.01% 10236
2022
Q4 		– Sell
-1,500
Closed -$211K – 12395
2022
Q3 		$211K Sell
1,500
-100
-6% -$15.1K ﹤0.01% 10699
2022
Q2 		$233K Buy
1,600
+100
+7% +$14.9K ﹤0.01% 10242
2022
Q1 		$243K Sell
1,500
-8,800
-85% -$1.43M ﹤0.01% 10770
2021
Q4 		$1.95M Buy
10,300
+1,300
+14% +$251K ﹤0.01% 5566
2021
Q3 		$1.82M Buy
9,000
+6,600
+275% +$1.39M ﹤0.01% 6046
2021
Q2 		$484K Buy
2,400
+400
+20% +$74.5K ﹤0.01% 9673
2021
Q1 		$351K Sell
2,000
-6,200
-76% -$1.12M ﹤0.01% 10283
2020
Q4 		$1.39M Buy
8,200
+3,700
+82% +$610K ﹤0.01% 5909
2020
Q3 		$729K Buy
4,500
+600
+15% +$97.6K ﹤0.01% 6871
2020
Q2 		$635K Sell
3,900
-2,700
-41% -$410K ﹤0.01% 6854
2020
Q1 		$845K Buy
6,600
+4,700
+247% +$633K ﹤0.01% 5777
2019
Q4 		$265K Sell
1,900
-22,400
-92% -$2.94M ﹤0.01% 8245
2019
Q3 		$2.87M Buy
24,300
+22,000
+957% +$2.74M ﹤0.01% 3564
2019
Q2 		$298K Buy
2,300
+300
+15% +$37K ﹤0.01% 8328
2019
Q1 		$257K Sell
2,000
-4,200
-68% -$531K ﹤0.01% 7481
2018
Q4 		$689K Buy
6,200
+3,000
+94% +$362K ﹤0.01% 5407
2018
Q3 		$436K Sell
3,200
-8,500
-73% -$1.11M ﹤0.01% 6788
2018
Q2 		$1.4M Buy
11,700
+9,700
+485% +$1.14M ﹤0.01% 4672
2018
Q1 		$241K Sell
2,000
-5,300
-73% -$665K ﹤0.01% 7995
2017
Q4 		$910K Sell
7,300
-4,100
-36% -$524K ﹤0.01% 5431
2017
Q3 		$1.53M Buy
11,400
+1,900
+20% +$247K ﹤0.01% 4420
2017
Q2 		$1.19M Buy
9,500
+3,900
+70% +$470K ﹤0.01% 4901
2017
Q1 		$667K Sell
5,600
-8,400
-60% -$982K ﹤0.01% 5957
2016
Q4 		$1.51M Buy
14,000
+3,800
+37% +$413K ﹤0.01% 4657
2016
Q3 		$1.18M Sell
10,200
-31,500
-76% -$3.59M ﹤0.01% 4500
2016
Q2 		$4.27M Buy
41,700
+4,800
+13% +$512K ﹤0.01% 2416
2016
Q1 		$3.83M Buy
36,900
+3,200
+9% +$334K ﹤0.01% 2680
2015
Q4 		$4.28M Sell
33,700
-17,500
-34% -$2.14M ﹤0.01% 2751
2015
Q3 		$5.85M Sell
51,200
-10,400
-17% -$1.38M ﹤0.01% 2455
2015
Q2 		$8.31M Buy
61,600
+11,800
+24% +$1.57M ﹤0.01% 2216
2015
Q1 		$6.45M Buy
49,800
+30,400
+157% +$3.82M ﹤0.01% 2388
2014
Q4 		$2.24M Sell
19,400
-6,700
-26% -$755K ﹤0.01% 4243
2014
Q3 		$2.76M Buy
26,100
+1,600
+7% +$162K ﹤0.01% 4044
2014
Q2 		$2.34M Sell
24,500
-11,000
-31% -$986K ﹤0.01% 4360
2014
Q1 		$3.23M Buy
35,500
+12,100
+52% +$1.18M ﹤0.01% 3525
2013
Q4 		$2.07M Buy
23,400
+11,600
+98% +$970K ﹤0.01% 4212
2013
Q3 		$976K Buy
11,800
+1,700
+17% +$133K ﹤0.01% 5313
2013
Q2 		$692K Buy
+10,100
New +$703K ﹤0.01% 5571

Other funds holding BBH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CCA
Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

Susquehanna International Group's BBH Position: Q1 2026 in Review

Susquehanna International Group increased its VanEck Biotech ETF (BBH) stake by 117% in Q1 2026, buying an estimated $268K and bringing the position to 2,579 shares worth $485K. The position accounts for ﹤0.01% of the portfolio, ranked #9756.

Susquehanna International Group first reported a position in BBH in Q2 2013 and has held it in 50 quarters since. The position peaked at $11M in Q4 2013. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

  • Susquehanna International Group held 2,579 shares of VanEck Biotech ETF worth $485K as of Q1 2026.
  • Susquehanna International Group bought 1,391 VanEck Biotech ETF shares in Q1 2026, an estimated $268K.
  • VanEck Biotech ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9756 holding.
  • Susquehanna International Group first reported a position in VanEck Biotech ETF in Q2 2013 and has held it in 50 quarters since.
  • Susquehanna International Group's VanEck Biotech ETF position peaked at $11M in Q4 2013.
  • 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.